148 related articles for article (PubMed ID: 30467104)
1. Lamotrigine Therapy for Bipolar Depression: Analysis of Self-Reported Patient Data.
Nzeyimana A; Saunders KE; Geddes JR; McSharry PE
JMIR Ment Health; 2018 Nov; 5(4):e63. PubMed ID: 30467104
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial.
Geddes JR; Gardiner A; Rendell J; Voysey M; Tunbridge E; Hinds C; Yu LM; Hainsworth J; Attenburrow MJ; Simon J; Goodwin GM; Harrison PJ;
Lancet Psychiatry; 2016 Jan; 3(1):31-39. PubMed ID: 26687300
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and genetic predictors and correlates of response to lamotrigine and folic acid in bipolar depression: Analysis of the CEQUEL clinical trial.
Tunbridge EM; Attenburrow MJ; Gardiner A; Rendell JM; Hinds C; Goodwin GM; Harrison PJ; Geddes JR
Bipolar Disord; 2017 Sep; 19(6):477-486. PubMed ID: 28833962
[TBL] [Abstract][Full Text] [Related]
4. Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL).
Simon J; Geddes JR; Gardiner A; Rendell J; Goodwin GM; Mayer S
Bipolar Disord; 2018 Dec; 20(8):733-745. PubMed ID: 30375699
[TBL] [Abstract][Full Text] [Related]
5. The Spanish version of the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR16): a psychometric analysis in a clinical sample.
Trujols J; de Diego-Adeliño J; Feliu-Soler A; Iraurgi I; Puigdemont D; Alvarez E; Pérez V; Portella MJ
J Affect Disord; 2014 Dec; 169():189-96. PubMed ID: 25212994
[TBL] [Abstract][Full Text] [Related]
6. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine.
McIntyre RS; Lipsitz O; Lui LMW; Rodrigues NB; Gill H; Nasri F; Ling R; Teopiz KM; Ho RC; Subramaniapillai M; Kratiuk K; Mansur RB; Jones BDM; Lee Y; Rosenblat JD
J Affect Disord; 2021 Nov; 294():592-596. PubMed ID: 34332360
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for a randomised placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment resistant bipolar depression (the PAX-BD study).
Azim L; Hindmarch P; Browne G; Chadwick T; Clare E; Courtney P; Dixon L; Duffelen N; Fouweather T; Geddes JR; Goudie N; Harvey S; Helter T; Holstein EM; Martin G; Mawson P; McCaffery J; Morriss R; Simon J; Smith D; Stokes PRA; Walker J; Weetman C; Wolstenhulme F; Young AH; Watson S; McAllister-Williams RH
BMC Psychiatry; 2021 Jul; 21(1):334. PubMed ID: 34225686
[TBL] [Abstract][Full Text] [Related]
8. Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Rush AJ; Trivedi MH; Carmody TJ; Ibrahim HM; Markowitz JC; Keitner GI; Kornstein SG; Arnow B; Klein DN; Manber R; Dunner DL; Gelenberg AJ; Kocsis JH; Nemeroff CB; Fawcett J; Thase ME; Russell JM; Jody DN; Borian FE; Keller MB
Neuropsychopharmacology; 2005 Feb; 30(2):405-16. PubMed ID: 15578008
[TBL] [Abstract][Full Text] [Related]
9. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
10. Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy(and folic acid vs placebo) in patients with bipolar depression (CEQUEL).
Silva Lima AFBD; Cohen M; Miguel S; Cruz L
Bipolar Disord; 2019 Mar; 21(2):172-173. PubMed ID: 30698326
[No Abstract] [Full Text] [Related]
11. A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use.
Gao K; Ganocy SJ; Conroy C; Brownrigg B; Serrano MB; Calabrese JR
Psychopharmacology (Berl); 2017 Aug; 234(15):2233-2244. PubMed ID: 28536866
[TBL] [Abstract][Full Text] [Related]
12. Individualized Web-Based Exercise for the Treatment of Depression: Randomized Controlled Trial.
Haller N; Lorenz S; Pfirrmann D; Koch C; Lieb K; Dettweiler U; Simon P; Jung P
JMIR Ment Health; 2018 Oct; 5(4):e10698. PubMed ID: 30314962
[TBL] [Abstract][Full Text] [Related]
13. Commentary on Simon et al. 2018: "Comparative economic evaluation of quetiapine plus lamotrigine combination vs quetiapine monotherapy (and folic acid vs placebo) in patients with bipolar depression (CEQUEL)".
Razzouk D
Bipolar Disord; 2019 Mar; 21(2):170-171. PubMed ID: 30548233
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial.
van der Loos ML; Mulder PG; Hartong EG; Blom MB; Vergouwen AC; de Keyzer HJ; Notten PJ; Luteijn ML; Timmermans MA; Vieta E; Nolen WA;
J Clin Psychiatry; 2009 Feb; 70(2):223-31. PubMed ID: 19200421
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.
Calabrese JR; Bowden CL; Sachs G; Yatham LN; Behnke K; Mehtonen OP; Montgomery P; Ascher J; Paska W; Earl N; DeVeaugh-Geiss J;
J Clin Psychiatry; 2003 Sep; 64(9):1013-24. PubMed ID: 14628976
[TBL] [Abstract][Full Text] [Related]
16. Psychometric validation of the 16 Item Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR16) in military veterans with PTSD.
Surís A; Holder N; Holliday R; Clem M
J Affect Disord; 2016 Sep; 202():16-22. PubMed ID: 27253212
[TBL] [Abstract][Full Text] [Related]
17. Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression.
Fancy F; Rodrigues NB; Di Vincenzo JD; Chau EH; Sethi R; Husain MI; Gill H; Tabassum A; Mckenzie A; Phan L; McIntyre RS; Rosenblat JD
Focus (Am Psychiatr Publ); 2023 Oct; 21(4):420-429. PubMed ID: 38694999
[TBL] [Abstract][Full Text] [Related]
18. Bipolar depression: a new role for atypical antipsychotics?
Keck PE
Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties of the Quick Inventory of Depressive Symptomatology (QIDS-SR) in UK primary care.
Cameron IM; Crawford JR; Cardy AH; du Toit SW; Lawton K; Hay S; Mitchell K; Sharma S; Shivaprasad S; Winning S; Reid IC
J Psychiatr Res; 2013 May; 47(5):592-8. PubMed ID: 23419617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
